Briacell Therapeutics Corp (BCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 07/31
10-2011 | 07-2011 | 04-2011 | 01-2011 | 10-2010 | |
Operating Expenses | 152 | 504 | 235 | 184 | 106 |
Operating Income | -152 | -504 | -235 | -184 | -106 |
Other Income | 19 | -18 | -8 | 2 | 1 |
Pre-tax Income | -133 | -522 | -243 | -182 | -104 |
Net Income Continuous | -133 | -522 | -243 | -182 | -104 |
Net Income | $-133 | $-533 | $-233 | $-182 | $-104 |
EPS Basic Total Ops | 0.00 | N/A | -3.15 | -3.00 | -2.91 |
EPS Basic Continuous Ops | -0.70 | 6.27 | -3.02 | -2.40 | -1.38 |
EPS Diluted Total Ops | 0.00 | N/A | -3.15 | -3.00 | -2.91 |
EPS Diluted Continuous Ops | -0.70 | 6.27 | -3.02 | -2.40 | -1.38 |
EBITDA(a) | $-152 | $-503 | $-234 | $-183 | $-105 |